Monthly focus

The age of anxiety

09 June 2020

Image credit - Unsplash/ Fabrizio Verrecchia

In June, against a backdrop of the coronavirus pandemic, a climate emergency and an uncertain future, Horizon takes a look at anxiety. Are we becoming more anxious? What do we really know about the condition and who suffers from it? And how can we best treat it? We speak to anxiety disorder expert Professor David Baldwin about when anxiety turns from a normal response into a long-term problem and what we know – and don’t – about why this happens. We take a look at one particularly vulnerable group – teenagers – to understand how anxiety affects them and how they can best be treated. We explore the link between anxiety and our awareness of bodily sensations to understand, for example, why breathing can calm the mind, and we also talk to the researchers who believe the key to improving anxiety therapies is to look at how different people respond when under threat.

health

29 June 2020

Does teenage anxiety have its roots in infancy?

The fact that teenagers worry isn’t necessarily a concern – it’s when the adolescent brain amplifies and distorts a simple worry that mental health problems can arise. As scientists aim to unlock why teenagers get anxious, and how infancy and upbringing are implicated, early intervention strategies are being refined to redirect harmful thoughts and teach adolescents to read the emotions of others – a crucial way to keep their own distressing feelings in check.

The way anxiety affects our perception of changes to our body, such as breathing, could pave the way for more targeted anxiety treatments. Image credit - www.pxfuel.com/Public domain

health

22 June 2020

What anxiety does to our breathing

Stressful situations can cause anxiety, our body’s natural response to stress. But feelings of apprehension can also be accompanied by physical effects such as rapid breathing, increased heart rate and nausea. How our brain perceives these physical changes – in particular, breathing – could be key to better understanding anxiety disorders and treating them.

Researchers are using virtual reality to test participants’ reactions to threats such as dogs or falling rocks to understand more about the brain mechanisms linked to anxiety. Image credit - needpix.com, public domain

health | frontier research

15 June 2020

By recreating phobias and panic attacks, neuroscientists aim to improve anxiety therapies

Tracking the brain’s reaction to virtual-reality-simulated threats such as falling rocks and an under-researched fear reduction strategy may provide better ways of treating anxiety disorders and preventing relapses.

Prof. Baldwin says there are still many gaps in our knowledge of how to treat anxiety disorders, especially when therapy and anti-depressants do not work. Image credit - David Baldwin

interview | health

09 June 2020

Q&A: When and how does anxiety become a problem?

Short-term anxiety is a normal response to stress, but more needs to be done to understand and treat longer-term anxiety disorders, which affect the lives of millions of people across Europe and impose a significant economic burden on society, according to Professor David Baldwin, head of the mental health group at the University of Southampton, UK.

Recommended for you

Insect biodiversity under threat

With around half a million species of insects reported to be at risk of extinction and studies already showing a large decline in abundance, this month Horizon looks at what reduced insect biodiversity means for us – and what we can do about it. We speak to rove beetle expert Dr Alexey Solodovnikov about the services insects provide, from waste disposal and pollination to monitoring climate change and providing information about a new pandemic. We find out how scientists hope to cut the use of pesticides – one of the big culprits for reducing insect diversity – with new ways of pest control. We look at how efforts to boost urban green space in Europe’s cities is impacting insect life and we ask whether people’s attitudes to insects affect conservation efforts.

Rethinking our supply chains

The coronavirus pandemic rattled our supply chains, putting them under intense pressure and forcing many to become aware of these complex systems that bring us food, medicine and other goods. Was 2020 a wake-up call to rethink supply chains? Or have they proved more robust than we feared and should continue as business as usual? In February, we ask whether today’s supply chains are due for reconfiguration. We speak to Dr Tessa Avermaete, a bioeconomist at KU Leuven in Belgium, about why short and local is not always better – or more sustainable – when it comes to food supply. We look at how medical supply chains can be maintained or even set up during a crisis situation, and at the environmental and social impacts of Europe’s supply chains on the rest of the world. And we look at how, in the future, goods from food to furniture could be transported according to new concept called the ‘physical internet’, where logistics mimics how information travels through the internet.

Insects such as rove beetles can reveal a lot about climate change and help us fight future disease outbreaks. Image credit - Aslak Kappel Hansen

Q&A: Climate monitoring, pandemic insight, decomposition – what insects do for us

Insects are vital to the health of our planet but they can also reveal a lot about climate change and help us fight future vector-borne disease outbreaks, says Alexey Solodovnikov, an associate professor at the University of Copenhagen, Denmark, who runs the rove beetle-dedicated Solodovnikov Lab and is a curator at the Natural History Museum of Denmark.

A repurposed old drug provides new treatment for people with the rare disease alkaptonuria. Image credit - Laurynas Mereckas/Unsplash

‘Never seen anything as effective’ – the not-so-new-drug repurposed for a rare disease

The earliest signs of alkaptonuria are often subtle and harmless, like a diaper stained black. However, over the years, this rare genetic disease can lead to a lifetime of surgery. Now, after 20 years of research, a not-so-new drug can offer relief for thousands of patients worldwide.

The age of anxiety

Republish this content